[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer

NCT02608216 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasm
Metastatic Breast Cancer
Rb+ Breast Cancer

Interventions

DRUG: [18F]FLT
DEVICE: PET/CT
DRUG: ribociclib
DRUG: paclitaxel

Sponsor

University of Pennsylvania